Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

4.1K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.1K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

4.6K
The pathophysiology of pneumonia involves the following steps:
4.6K
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

22
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
22
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

1.4K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.4K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

1.3K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.3K
Pneumonia IV: Management01:28

Pneumonia IV: Management

1.2K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Vitro hRPTEC TERT1 Model for Uranium-Induced Nephrotoxicity Pathway Study.

Journal of toxicology·2026
Same author

Characterizing the Immune Response in Pig-to-Human Heart Xenografts Using a Multimodal Diagnostic System.

Circulation·2025
Same author

Inhibition of eIF5A hypusination enhances antioxidant defense to prevent kidney Ischemia/Reperfusion injury.

Redox biology·2025
Same author

Effects of super high-flux vitamin E-coated and medium cut-off dialyzers on uremic toxins removal and biocompatibility: the E-FLUX randomized controlled study.

Clinical kidney journal·2025
Same author

Dynamic conditioning of porcine kidney grafts with extracellular vesicles derived from urine progenitor cells: A proof-of-concept study.

Clinical and translational medicine·2024
Same author

Drug-induced impairment of mitochondrial fatty acid oxidation and steatosis: assessment of causal relationship with 45 pharmaceuticals.

Toxicological sciences : an official journal of the Society of Toxicology·2024

Related Experiment Video

Updated: Apr 28, 2026

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

14.5K

[Varicella pneumonia]

Arnaud Bouvet, Sebastien Giraud, Pascal Malouli

    La Revue Du Praticien
    |June 14, 2014
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 2
    10:55

    Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 2

    Published on: April 10, 2009

    6.8K
    Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 1
    12:00

    Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 1

    Published on: April 8, 2009

    9.1K

    Related Experiment Videos

    Last Updated: Apr 28, 2026

    Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
    08:04

    Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

    Published on: July 9, 2014

    14.5K
    Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 2
    10:55

    Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 2

    Published on: April 10, 2009

    6.8K
    Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 1
    12:00

    Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 1

    Published on: April 8, 2009

    9.1K